- Home
- CNTB vs ONL Comparison
CNTB vs ONL Comparison
Compare CNTB & ONL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTB | ONL |
|---|---|---|
| Founded | 2012 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 128.6M | 113.2M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNTB | ONL |
|---|---|---|
| Price | $2.69 | $2.58 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $8.50 | $3.00 |
| AVG Volume (30 Days) | 90.3K | ★ 322.9K |
| Earning Date | 04-02-2026 | 03-05-2026 |
| Dividend Yield | N/A | ★ 3.09% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $762,000.00 | ★ $149,775,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $24,739.01 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.51 | $1.46 |
| 52 Week High | $3.28 | $4.25 |
Technical Indicators
Market Signals| Indicator | CNTB | ONL |
|---|---|---|
| Relative Strength Index (RSI) | 52.37 | 66.51 |
| Support Level | $2.46 | $2.15 |
| Resistance Level | $2.70 | $2.67 |
| Average True Range (ATR) | 0.25 | 0.14 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 57.89 | 85.12 |
Price Performance
Historical ComparisonAbout CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About ONL Orion Office REIT Inc.
Orion Properties Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased on a single-tenant net lease basis to creditworthy clients. The portfolio of the company includes traditional office buildings, governmental offices, medical offices, laboratories, and others. The Company operates in one business segment: direct ownership and operation of commercial real estate.